Clinical Trial

Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 3, 2025 (before its estimated April 24, 2025 completion). Its status may not reflect the trial's current state.
Summary
Pharmacokinetics and pharmacodynamics study of 2 formulations (human insulin enteric coated capsules 32mg vs. human insulin injection 5IU) Relative biopotency and bioavailability of human insulin enteric coated capsules 32mg vs. human insulin injection 5IU
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-24.
Trial Details
NCT Number NCT06901726
Lead Sponsor Shanghai Jiao Tong University School of Medicine
Conditions Diabetes Mellitus
Enrollment 10 participants
Start Date 2025-03-31
Primary Completion 2025-04-24 (estimated)
Study Completion 2025-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-03